ROBERTI, DOMENICO
 Distribuzione geografica
Continente #
EU - Europa 3.169
AS - Asia 1.350
NA - Nord America 1.251
SA - Sud America 239
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.035
Nazione #
RU - Federazione Russa 2.287
US - Stati Uniti d'America 1.209
SG - Singapore 441
IT - Italia 312
CN - Cina 303
IE - Irlanda 209
BR - Brasile 198
VN - Vietnam 175
HK - Hong Kong 172
DE - Germania 108
KR - Corea 76
GB - Regno Unito 68
IN - India 49
JP - Giappone 38
FR - Francia 32
FI - Finlandia 27
UA - Ucraina 26
PK - Pakistan 22
AR - Argentina 21
CA - Canada 21
NL - Olanda 19
AT - Austria 17
ID - Indonesia 16
TR - Turchia 15
MX - Messico 13
SE - Svezia 13
GR - Grecia 10
BD - Bangladesh 8
EC - Ecuador 8
CZ - Repubblica Ceca 6
PL - Polonia 6
ZA - Sudafrica 6
BE - Belgio 5
ES - Italia 5
ET - Etiopia 5
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
DZ - Algeria 3
IQ - Iraq 3
MA - Marocco 3
MY - Malesia 3
PH - Filippine 3
PT - Portogallo 3
PY - Paraguay 3
SA - Arabia Saudita 3
TH - Thailandia 3
TN - Tunisia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CL - Cile 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
JO - Giordania 2
LT - Lituania 2
MK - Macedonia 2
PE - Perù 2
RS - Serbia 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CH - Svizzera 1
CO - Colombia 1
CY - Cipro 1
EG - Egitto 1
GD - Grenada 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MQ - Martinica 1
MT - Malta 1
NG - Nigeria 1
OM - Oman 1
PS - Palestinian Territory 1
SV - El Salvador 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.035
Città #
Moscow 849
San Jose 283
Singapore 218
Dublin 209
Hong Kong 169
Santa Clara 153
Ashburn 80
Chandler 77
Seoul 75
Hefei 68
Naples 61
New York 54
Ho Chi Minh City 49
Beijing 44
Hanoi 44
Jacksonville 44
Caserta 42
Bengaluru 39
Munich 35
Dallas 30
Ann Arbor 23
Princeton 23
The Dalles 23
Bremen 21
São Paulo 21
Roxbury 20
Ercolano 19
Rome 17
Los Angeles 14
Medford 14
Helsinki 13
Cambridge 12
Da Nang 12
Nuremberg 12
Woodbridge 12
Boardman 11
Falkenstein 10
Hải Dương 10
Vienna 10
Amsterdam 9
Des Moines 9
Hillsboro 9
Napoli 9
Orem 9
Atlanta 8
Aversa 8
Pozzuoli 8
Belo Horizonte 7
Istanbul 7
London 7
Nanjing 7
Turku 7
Wilmington 7
Bologna 6
Brno 6
Islamabad 6
Johannesburg 6
Lahore 6
Milan 6
Montreal 6
Nocera Inferiore 6
Shanghai 6
Curitiba 5
Elora 5
Grumo Nevano 5
Haiphong 5
Jakarta 5
Memphis 5
Redwood City 5
San Mateo 5
Tokyo 5
Toronto 5
Warsaw 5
Brasília 4
Brussels 4
Chicago 4
Cutrofiano 4
Frankfurt am Main 4
Kunming 4
Nemoli 4
Quito 4
Rio de Janeiro 4
Salvador 4
Seattle 4
Shenzhen 4
Thái Nguyên 4
Afragola 3
Bangkok 3
Boston 3
Buffalo 3
Campinas 3
Cercola 3
Charlotte 3
Copenhagen 3
Council Bluffs 3
Duque de Caxias 3
Düsseldorf 3
Goiânia 3
Guangzhou 3
Jackson 3
Totale 3.234
Nome #
Effects of germline VHL deficiency on growth, metabolism, and mitochondria 219
A cancer-associated CDKN1B mutation induces p27 phosphorylation on a novel residue: a new mechanism for tumor suppressor loss-of-function 202
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura. 186
HNF-1β mutation affects PKD2 and SOCS3 expression causing renal cysts and diabetes in MODY5 kindred. 185
Hereditary hypochromic microcytic anemia associated with loss-of-function DMT1 gene mutations and absence of liver iron overload 174
Auditory cortex hypoperfusion: a metabolic hallmark in Beta Thalassemia 173
Asymptomatic intracranial aneurysms in beta-thalassemia: A three-year follow-up report 167
Effect of CB2 Stimulation on Gene Expression in Pediatric B-Acute Lymphoblastic Leukemia: New Possible Targets 159
EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors. 157
A Novel 12q13.2-q13.3 Microdeletion Syndrome With Combined Features of Diamond Blackfan Anemia, Pierre Robin Sequence and Klippel Feil Deformity 157
ERITROCITOSI CONGENITA CAUSATA DA ALTERAZIONI DEL SISTEMA SENSORE DELL’OSSIGENO 150
Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy 149
CB2 Receptor as Emerging Anti-Inflammatory Target in Duchenne Muscular Dystrophy 147
p27Kip1, an Intrinsically Unstructured Protein with Scaffold Properties 146
Childhood Multiple Endocrine Neoplasia (MEN) Syndromes: Genetics, Clinical Heterogeneity and Modifying Genes 141
Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multicentre nation-wide cohort 138
Transient erythroblastopenia of childhood after COVID-19 infection: a case report 137
Brain perfusion changes in beta-thalassemia 132
Bone Health Impairment in Patients with Hemoglobinopathies: From Biological Bases to New Possible Therapeutic Strategies 127
Share Role of Nutraceuticals in Counteracting Inflammation in In Vitro Macrophages Obtained from Childhood Cancer Survivors. 126
Long-term improvement in cardiac magnetic resonance in β-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function 125
Headache in beta-thalassemia: An Italian multicenter clinical, conventional MRI and MR-angiography case-control study 125
Characterisation of transfusion-dependent prediabetes using continuous glucose monitoring: The Haemoglycare study 119
Response to measles, mumps and rubella (Mmr) vaccine in transfusion-dependent patients 109
CB2 and TRPV1 receptors in inflammatory state of macrophages from sickle cell anemia pediatric/young adults 106
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection 105
Abstract LB_A12: Initial results from 2 Phase I studies of NMS-03305293, a selective PARP1 inhibitor 104
Altered branched chain ketoacids underlie shared metabolic phenotypes in type 1 diabetes and maple syrup urine disease 99
Abstract 509: The MPS1/TTK inhibitor, NMS-01940153, synergizes with tisotumab vedotin in colorectal cancer 99
Effects of Eltrombopag on In Vitro Macrophage Polarization in Pediatric Immune Thrombocytopenia 99
Underlying disease is the main risk factor in post-splenectomy complication risk: Data from a national database 98
No increased cerebrovascular involvement in adult beta-thalassemia by advanced MRI analyses 96
Cognitive impairment in hereditary spherocytosis 95
Familial neurohypophyseal diabetes insipidus in 13 kindreds and 2 novel mutations in the vasopressin gene 95
The efficacy and the safety of Eltrombopag in pediatric patients with Severe Aplastic Anemia: a systematic review 94
Screening for sickle cell disease by point-of-care tests in Italy: pilot study on 1000 at risk children 93
NMS-01940153E, an MPS1 inhibitor with anti-tumor activity in relapsed or refractory unresectable Hepatocellular carcinoma 91
White matter volume changes in adult beta-thalassemia: Negligible and unrelated to anemia and cognitive performances 90
Long‐term outcomes of avascular necrosis in sickle cell disease using joint‐specific patient‐reported outcome measures: Results from a multicentre study 87
Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome 87
The interactome of the N-terminus of band 3 regulates red blood cell metabolism and storage quality 86
Thyroid Nodule Surveillance in Transfusion-Dependent Thalassemia: A Comparative Ultrasonographic Study 83
TIMELESS Forms a Complex with PARP1 Distinct from Its Complex with TIPIN and Plays a Role in the DNA Damage Response 80
Thalassemia-Associated mixed hypogonadism (TAMH): unraveling a unique endocrine pattern and its impact on cardiovascular risk 79
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry 79
Pregnancy and childbirth in women with thalassemia: past and present 76
PARP1-dependent recruitment of the FBXL10-RNF68-RNF2 ubiquitin ligase to sites of DNA damage controls H2A.Z loading 75
Recent BCR stimulation induces a negative autoregulatory loop via FBXO10 mediated degradation of HGAL 74
Luspatercept for Transfusion‐Dependent Beta‐Thalassemia: Real‐World Experience in a Large Cohort of Patients From Italy 69
Phase II study on safety and efficacy of NMS-01940153E, an MPS1 inhibitor with first-in-class potential, in adult patients with unresectable hepatocellular carcinoma (HCC) previously treated with systemic therapy 69
‘Phenoconversion’ in adult patients with β‐thalassemia 68
Pretransfusion hemoglobin level and mortality in adults with transfusion-dependent β-thalassemia 66
null 53
Corrigendum to "Characterisation of transfusion-dependent prediabetes using continuous glucose monitoring: The Haemoglycare study" [Diab. Res. Clin. Pract. 222 (2025) 112076] 21
Disease Burden in Transfusion-Dependent β-Thalassemia (TDT) Patients and Caregivers in Italy: Results of a Cross-Sectional Descriptive Online Survey 12
Totale 6.178
Categoria #
all - tutte 19.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.340


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 0 6
2021/2022223 7 8 16 8 50 8 28 20 6 10 15 47
2022/2023406 36 14 13 15 48 31 4 16 196 4 19 10
2023/2024203 7 8 17 10 47 40 1 10 7 4 17 35
2024/2025864 10 12 4 35 138 91 154 85 107 74 79 75
2025/20264.171 163 264 245 226 363 2.121 180 241 143 118 69 38
Totale 6.178